Short answer. Yes. Under Section 88 of RA 9165, the Chairman of the Dangerous Drugs Board must submit an annual report on the country's drug situation to the President and to the presiding officers of both houses of Congress within fifteen days from the opening of each regular session, covering programs, drug-crime statistics, expenses, and any recommended legislation.
What the law says
The Board shall manage the funds as it may deem proper for the attainment of the objectives of this Act.
RA 9165, Section 88 — Fund Management And Annual Report. Read the full provision →
What the law says
an annual report on the dangerous drugs situation in the country
RA 9165, Section 88 — Fund Management And Annual Report. Read the full provision →
Managing the funds
The Dangerous Drugs Board is given authority to manage the funds appropriated under RA 9165 in whatever way it considers proper to achieve the law's objectives. This covers funding for the Board's own operations as well as programs carried out with the Philippine Drug Enforcement Agency, ranging from prevention campaigns to treatment and rehabilitation support. The provision does not fix a rigid formula; it leaves allocation decisions to the Board's judgment, subject to the annual reporting duty and the separate audit the law imposes elsewhere.
What goes into the annual report
Section 88 requires more than a token summary. The Chairman must give a detailed account of the programs and projects the Board and PDEA carried out that year, statistics on crimes connected to dangerous drugs, a record of expenses incurred under the Act, and any remedial legislation the Board believes Congress should consider. The report is meant to give lawmakers a full picture of both what enforcement accomplished and what it cost, not just headline arrest figures.
Submission deadline and recipients
The annual report goes to two places at once: the President of the Philippines and the presiding officers of both the Senate and the House of Representatives. It is due within fifteen days from the opening of each regular session of Congress, so lawmakers receive it near the start of their legislative calendar rather than buried mid-session. This obligation exists on top of, not instead of, any other periodic reports the Board may already owe under other parts of the Act.
Why the reporting duty matters
A standing annual report gives Congress a built-in checkpoint on how drug-enforcement funds are spent and whether the current law is working, without needing a special inquiry to force disclosure. It also creates a public record that citizens, researchers, and legal practitioners can consult when assessing how the anti-drug campaign is being run in a given year, and it works alongside the separate audit requirement covering the Board's and PDEA's accounts under a companion provision of the same Act.
Related provisions
- RA 9165, Section 88 — Fund Management And Annual Report
- RA 9165, Section 89 — Audit Of Board And PDEA